Literature DB >> 20457836

Dynamic changes in the TRPA1 selectivity filter lead to progressive but reversible pore dilation.

T G Banke1, S R Chaplan, A D Wickenden.   

Abstract

TRPA1 is a nonselective cation channel belonging to the transient receptor potential (TRP) family that is expressed in peripheral sensory neurons and may play important roles in pain perception and inflammation. We found that agonist stimulation of TRPA1, along with other members of the TRP family (TRPV1-4 and TRPM8), can induce the appearance of a large pore permeable to large organic cations such as Yo-Pro (YP) and N-methyl-d-glucamine, in an agonist and divalent cation-dependent manner. YP uptake was not inhibited by a panel of putative gap junction/pannexin blockers, suggesting that gap junction proteins are not required in this process. Our data suggest that changes in the TRP channel selectivity filter itself result in a progressive but reversible pore dilation process, a process that is under strong regulation by external calcium ions. Our data suggest that calcium plays a novel role in setting the amount of time TRPA1 channels spend in a dilated state providing a mechanism that may limit sensory neuron activation by painful or irritating substances.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20457836     DOI: 10.1152/ajpcell.00489.2009

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  51 in total

Review 1.  Irritating channels: the case of TRPA1.

Authors:  Bernd Nilius; Jean Prenen; Grzegorz Owsianik
Journal:  J Physiol       Date:  2010-11-15       Impact factor: 5.182

2.  The pore properties of human nociceptor channel TRPA1 evaluated in single channel recordings.

Authors:  Y V Bobkov; E A Corey; B W Ache
Journal:  Biochim Biophys Acta       Date:  2010-12-29

Review 3.  TRPing on the pore phenomenon: what do we know about transient receptor potential ion channel-related pore dilation up to now?

Authors:  L G B Ferreira; R X Faria
Journal:  J Bioenerg Biomembr       Date:  2016-01-04       Impact factor: 2.945

4.  Opening of an alternative ion permeation pathway in a nociceptor TRP channel.

Authors:  Joris Vriens; Katharina Held; Annelies Janssens; Balázs István Tóth; Sara Kerselaers; Bernd Nilius; Rudi Vennekens; Thomas Voets
Journal:  Nat Chem Biol       Date:  2014-01-05       Impact factor: 15.040

5.  Contributions of space-clamp errors to apparent time-dependent loss of Mg2+ block induced by NMDA.

Authors:  Min-Yu Sun; Mariangela Chisari; Lawrence N Eisenman; Charles F Zorumski; Steven J Mennerick
Journal:  J Neurophysiol       Date:  2017-03-29       Impact factor: 2.714

6.  Role of the outer pore domain in transient receptor potential vanilloid 1 dynamic permeability to large cations.

Authors:  Clare H Munns; Man-Kyo Chung; Yuly E Sanchez; L Mario Amzel; Michael J Caterina
Journal:  J Biol Chem       Date:  2015-01-07       Impact factor: 5.157

Review 7.  How the TRPA1 receptor transmits painful stimuli: Inner workings revealed by electron cryomicroscopy.

Authors:  Monique S J Brewster; Rachelle Gaudet
Journal:  Bioessays       Date:  2015-09-21       Impact factor: 4.345

8.  Physical basis of apparent pore dilation of ATP-activated P2X receptor channels.

Authors:  Mufeng Li; Gilman E S Toombes; Shai D Silberberg; Kenton J Swartz
Journal:  Nat Neurosci       Date:  2015-09-21       Impact factor: 24.884

9.  Directionality of temperature activation in mouse TRPA1 ion channel can be inverted by single-point mutations in ankyrin repeat six.

Authors:  Sairam Jabba; Raman Goyal; Jason O Sosa-Pagán; Hans Moldenhauer; Jason Wu; Breanna Kalmeta; Michael Bandell; Ramon Latorre; Ardem Patapoutian; Jörg Grandl
Journal:  Neuron       Date:  2014-05-08       Impact factor: 17.173

10.  A novel TRPA1 variant is associated with carbamazepine-responsive cramp-fasciculation syndrome.

Authors:  M J Nirenberg; R Chaouni; T M Biller; R M Gilbert; C Paisán-Ruiz
Journal:  Clin Genet       Date:  2017-07-10       Impact factor: 4.438

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.